Listed

Soligenix, Inc.

SNGXNasdaqCIK 812796HealthcareFiscal year ends Dec 31

Reports and events: 350 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Soligenix, Inc., Reports and events
FiledFormWhat it isAccession number
2026-09-2120:30 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-109329
2026-08-0720:05 ET10-QQuarterly reportPeriod 2026-06-300001104659-26-092681
2026-08-0320:05 ETDEF 14AProxy statementPeriod 2026-09-170001104659-26-089789
2026-06-2620:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-078251
2026-06-1220:05 ET8-K3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-073430
2026-05-2821:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-067649
2026-05-0820:05 ET10-QQuarterly reportPeriod 2026-03-310001104659-26-057904
2026-04-2811:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-049787
2026-03-3120:05 ET10-KAnnual reportPeriod 2025-12-310001104659-26-037701
2026-02-1221:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-014267
2026-01-2321:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-006233
2025-11-1821:05 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001104659-25-113645
2025-11-0721:06 ET10-QQuarterly reportPeriod 2025-09-300001104659-25-108475
2025-09-2920:22 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-094507
2025-09-1921:01 ETS-1Registration statement0001104659-25-091717
2025-08-1813:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-25-011625
2025-08-1521:17 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001558370-25-011619
2025-08-1420:05 ET10-QQuarterly reportPeriod 2025-06-300001558370-25-011554
2025-07-3120:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-072708
2025-06-2020:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001558370-25-008772
2025-05-0920:05 ET10-QQuarterly reportPeriod 2025-03-310001558370-25-007171
2025-05-0520:05 ETDEF 14AProxy statementPeriod 2025-06-200001104659-25-044504
2025-03-2820:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001558370-25-003987
2025-03-2120:05 ET10-KAnnual reportPeriod 2024-12-310001558370-25-003459
2025-02-1012:30 ET8-K1.02 Termination of a material agreement0001558370-25-000726
2024-11-0821:06 ET10-QQuarterly reportPeriod 2024-09-300001558370-24-015054
2024-10-1120:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001558370-24-013257
2024-08-1620:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-24-012345
2024-08-0920:05 ET10-QQuarterly reportPeriod 2024-06-300001558370-24-011740
2024-07-2511:30 ET8-K1.01 Entry into a material agreement0001558370-24-010107
2024-07-2421:28 ETS-1Registration statement0001558370-24-010061
2024-07-0917:28 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001558370-24-009712
2024-05-3112:00 ET8-K3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-24-008803
2024-05-2420:05 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-24-008642
2024-05-1720:25 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-24-008421
2024-05-1020:05 ET10-QQuarterly reportPeriod 2024-03-310001558370-24-007782
2024-04-2920:01 ETDEF 14AProxy statementPeriod 2024-05-230001104659-24-053983
2024-04-2220:05 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-24-005411
2024-04-0320:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-24-004663
2024-04-0221:06 ETS-1/ARegistration statement, amended0001558370-24-004621
2024-03-1520:19 ETS-1/ARegistration statement, amended0001558370-24-003415
2024-03-1520:06 ET10-KAnnual reportPeriod 2023-12-310001558370-24-003402
2024-01-1622:46 ETS-1Registration statement0001558370-24-000253
2023-12-2221:05 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001558370-23-019993
2023-12-1521:03 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001558370-23-019838
2023-11-1721:05 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-23-019193
2023-11-1321:00 ET10-QQuarterly reportPeriod 2023-09-300001558370-23-018818
2023-10-2020:05 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-23-016573
2023-09-2220:05 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-23-015942
2023-09-1520:05 ET8-K4.01 Change of auditor; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-23-015812

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.